Literature DB >> 11979152

Optimization of contrast dosage for gadobenate dimeglumine-enhanced high-resolution whole-body 3D magnetic resonance angiography.

Mathias Goyen1, Christoph U Herborn, Thomas C Lauenstein, Jörg Barkhausen, Patrick Veit, Silke Bosk, Jörg Debatin, Stefan G Ruehm.   

Abstract

RATIONALE AND
OBJECTIVES: To determine the optimal dose of gadobenate dimeglumine for diagnostic high-resolution whole-body 3D-MR angiography.
METHODS: Ten healthy volunteers were examined three times with an ascending dose of Gd-BOPTA (0.1/0.2/0.3 mmol/kg BW). Three-dimensional data sets were collected with a rolling table platform (AngioSURF; MR-Innovation GmbH, Essen, Germany) which integrates the torso surface coil, using a 3D FLASH sequence at five stations from carotid arteries to the trifurcation vessels in 72 seconds. SNR- and contrast-to-noise-values were calculated for 30 segments per patient. For qualitative evaluation a 4-point-visualization scale was used.
RESULTS: Overall, significantly (P < 0.05) higher signal-to-noise values and CNR values were determined for Gd-BOPTA at a dose of 0.2 and 0.3 mmol/kg compared with 0.1 mmol/kg. Similarly, the qualitative analysis demonstrated image quality to be superior with 0.2 and 0.3 mmol/kg compared with 0.1 mmol/kg (P < 0.05). Qualitative and quantitative assessment failed to demonstrate a statistically significant difference between 0.2 and 0.3 mmol/kg BW (P > 0.05).
CONCLUSION: A dose of 0.2 mmol/kg BW Gd-BOPTA rendered diagnostic image quality in all vascular segments of all volunteers.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11979152     DOI: 10.1097/00004424-200205000-00004

Source DB:  PubMed          Journal:  Invest Radiol        ISSN: 0020-9996            Impact factor:   6.016


  6 in total

1.  [Cardiovascular whole-body MRI: possibilities and limitations in prevention].

Authors:  C U Herborn; F M Vogt; M Goyen; S C Goehde; S G Ruehm; M Forsting
Journal:  Radiologe       Date:  2004-09       Impact factor: 0.635

Review 2.  [Whole body MRI--diagnostic strategy of the future?].

Authors:  M Goyen; H-P Schlemmer
Journal:  Radiologe       Date:  2007-10       Impact factor: 0.635

Review 3.  Whole-Body MRA.

Authors:  Harald Kramer; Harald H Quick; Bernd Tombach; Stefan O Schoenberg; Joerg Barkhausen
Journal:  Eur Radiol       Date:  2008-05-20       Impact factor: 5.315

4.  Total-body 3D magnetic resonance angiography influences the management of patients with peripheral arterial occlusive disease.

Authors:  Mathias Goyen; Christoph U Herborn; Knut Kröger; Stefan G Ruehm; Jörg F Debatin
Journal:  Eur Radiol       Date:  2005-09-21       Impact factor: 5.315

5.  MR-based full-body preventative cardiovascular and tumor imaging: technique and preliminary experience.

Authors:  Mathias Goyen; Susanne C Goehde; Christoph U Herborn; Peter Hunold; Florian M Vogt; Elke R Gizewski; Thomas C Lauenstein; Waleed Ajaj; Michael Forsting; Jörg F Debatin; Stefan G Ruehm
Journal:  Eur Radiol       Date:  2004-02-13       Impact factor: 5.315

Review 6.  Gadobenate dimeglumine (MultiHance) for magnetic resonance angiography: review of the literature.

Authors:  M Goyen; J F Debatin
Journal:  Eur Radiol       Date:  2003-11       Impact factor: 7.034

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.